Data for validation and adjustment of APACHE II score in cardiogenic shock patients treated with a percutaneous left ventricular assist device
Johannes Mierke,
Thomas Nowack,
Tobias Loehn,
Franziska Kluge,
Frederike Poege,
Felix Woitek,
Norman Mangner,
Karim Ibrahim,
Axel Linke,
Christian Pfluecke
Affiliations
Johannes Mierke
Technische Universität Dresden, Department of Internal Medicine and Cardiology, Herzzentrum Dresden, University Clinic, Dresden, Germany; Corresponding author at: Fetscherstraße 76, 01307 Dresden, Germany.
Thomas Nowack
Technische Universität Dresden, Department of Internal Medicine and Cardiology, Herzzentrum Dresden, University Clinic, Dresden, Germany
Tobias Loehn
Kreiskrankenhaus Freiberg, Klinik für Innere Medizin II, Freiberg, Germany
Franziska Kluge
Technische Universität Dresden, Department of Internal Medicine and Cardiology, Herzzentrum Dresden, University Clinic, Dresden, Germany
Frederike Poege
Technische Universität Dresden, Department of Internal Medicine and Cardiology, Herzzentrum Dresden, University Clinic, Dresden, Germany
Felix Woitek
Technische Universität Dresden, Department of Internal Medicine and Cardiology, Herzzentrum Dresden, University Clinic, Dresden, Germany
Norman Mangner
Technische Universität Dresden, Department of Internal Medicine and Cardiology, Herzzentrum Dresden, University Clinic, Dresden, Germany
Karim Ibrahim
Klinikum Chemnitz, Klinik für Innere Medizin I, Chemnitz, Germany
Axel Linke
Technische Universität Dresden, Department of Internal Medicine and Cardiology, Herzzentrum Dresden, University Clinic, Dresden, Germany
Christian Pfluecke
Technische Universität Dresden, Department of Internal Medicine and Cardiology, Herzzentrum Dresden, University Clinic, Dresden, Germany
A precise prognosis is of imminent importance in intensive care medicine. This article provides data showing the overestimation of intrahospital mortality by APACHE II score in various subgroups of cardiogenic shock patients treated with a percutaneous left ventricular assist device. The data set includes additional baseline characteristics regarding age, pre-existing diseases, characteristics of coronary artery disease, characteristics of cardiopulmonary resuscitation, and hemodynamic parameter not included in the APACHE II score. Further data were provided which characterize derivation and validation group. Both groups were used for adjustment of the APACHE II approach. The data are supplemental to our original research article titled “Predictive value of the APACHE II score in cardiogenic shock patients treated with a percutaneous left ventricular assist device” (Mierke et al., IJC Heart & Vasculature. 40 (2022) 101013. https://doi.org/10.1016/j.ijcha.2022.101013).
